Media Coverage

2022

12/05/2022

Proteomics International awarded funding to support diabetic kidney disease test development – The Market Herald

12/04/2022

New Clinical Advisory Board to support PromarkerD global rollout – Yahoo! Finance

24/03/2022

Indian IP win gives Proteomics massive global cover – The West Australian

22/02/2022

Proteomics eyes Medicare for rebate inclusion – The West Australian

04/02/2022

Study results emerge for Proteomics International Laboratories’ latest cancer diagnostic test – The Sentiment

2021

16/12/2021

Proteomics wins biotech testing contract – The West Australian

14/12/2021

Proteomics International Laboratories (ASX:PIQ) receives $1.2 million R&D incentive – The Market Herald

23/11/2021

Proteomics enters lucrative UK market for kidney test – The West Australian

23/11/2021

PromarkerD distribution network expands to Britain – Yahoo! Finance

05/11/2021

PromarkerD significantly outperforms current standard of care tests in predicting future kidney function decline – Market Watch

03/11/2021

Proteomics (ASX:PIQ) awarded $100,000 project grant – The Market Herald

18/10/2021

Clinical study boosts Proteomics kidney test – The West Australian

12/08/2021

Proteomics International Laboratories (ASX:PIQ) contracts Biotem to manufacture test kits – The Market Herald

12/08/2021

Blood test or crystal ball? Looking into the future of our health – The Sentiment

10/08/2021

Endometriosis Blood Test – ABC Radio

1
2
3
4
5
6
7
8
9